TITLE

PRONEURON STARTS 2ND PHASE 1 SPINAL CORD INJURY CLINICAL TRIAL

PUB. DATE
December 2001
SOURCE
Worldwide Biotech;Dec2001, Vol. 13 Issue 12, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Deals with the Phase 1 clinical trials for the autologous activated macrophage therapy for patients with complete spinal cord injury by Proneuron Biotechnologies at the Erasme Hospital in Brussels, Belgium. Design of the study; Significance of the trials; Basis of the therapy.
ACCESSION #
7120953

 

Related Articles

  • BIO, ASCO, and Clinical Trials. Henderson, Lisa // Applied Clinical Trials;May2009, Vol. 18 Issue 5, p12 

    The article discusses various reports published within the issue, including one on the benefits of early strategic development planning, another one on radiological measurement quality improvement, and a report on ways which could prove beneficial for biotech development in clinical trial stage.

  • Clinic Roundup.  // BioWorld Today;7/9/2010, Vol. 21 Issue 131, p2 

    This section offers news briefs on clinical trials in the biotechnology industry as of July 9, 2010, including the initial Phase I study for EP217609 in patients with thrombin generation from Endotis Pharma, the histology study of azficel-T by Fibrocell Science Inc. and the drug application of...

  • Clinical development?look before you leap. Fox, Anthony W. // Nature Biotechnology;Jun2001 Supplement 6, Vol. 19, pBE27 

    Focuses on measures to be taken by small biotechnology companies for the clinical trials of drug development. Measurement of tolerability and pharmokinetics of the drug in healthy human volunteers; Studies on a limited number of patients with the specified conditions; Evidence of the safety and...

  • Biotechnology and Clinical Trials. Siegel, Jay P. // Journal of Infectious Diseases;2/15/2002 Supplement, Vol. 185, pS52 

    Not surprisingly, clinical trials have been critically important to developments in the field of biotechnology. Perhaps less expectedly, the clinical trials of biotechnology products have been critically important to recent developments in the field of clinical trials design, conduct, and...

  • Clinic Roundup.  // BioWorld Today;9/2/2011, Vol. 22 Issue 171, p4 

    This section offers world news briefs relating to clinical trials in the biopharmaceutical industry as of September 2, 2011, including the enrollment of patients for the Phase IIb trial of KUR211 in diabetic foot ulcers by Kuros Biosurgery AG, the clearance received by ReNeuron Ltd. from an...

  • Major Meetings in 2012.  // Contract Pharma;2012 Corporate Capabilities, Vol. 13 Issue 10, p401 

    A calendar of events from February 14, 2012 to November 14, 2012 is presentd which includes the Partnerships in Clinical Trials to be held in Orlando, Florida on March 5-7, the AAPS National Biotech Conference to be held in San Diego, California on May 21-23, and the DIA Annual Meeting to be...

  • CancerVax, Kalypsys Land $83M in New Funding. Webb, Marion // San Diego Business Journal;4/8/2002, Vol. 23 Issue 14, p14 

    Reports on the fundings of biotechnology firms CancerVax Corp. and Kalypsys Inc. in San Diego, California. Use of the money for the development of biotechnology products; Evaluation of the cancer vaccine; Permission of the testing of the vaccine by the Food and Drug Administration.

  • Business News.  // Applied Clinical Trials;Sep2000, Vol. 9 Issue 9, p74 

    Reports developments related to the pharmaceutical and biotechnology industries in support for clinical trials in the United States as of September 2000. Agreements for joint medical ventures of companies; Mergers and product launching of medical companies; Expansion of clinical trial...

  • On-Site Monitoring of German Clinical Trials. Busch-Heidger, Barbara; Hecht, Arthur; Ansmann, Eva B.; Gertzen, Heiner // Applied Clinical Trials;Jun2001, Vol. 10 Issue 6, p84 

    Presents a survey of the extent of clinical trial monitoring in Germany, conducted by a team from the German Association of Research-Based Pharmaceutical Companies subcommittee on good clinical practice and the Clinical Quality Assurance Group. Themes on on-site monitoring; Extent and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics